Yoshimasa Imoto1, Atsushi Kato2, Tetsuji Takabayashi3, Whitney Stevens4, James E Norton4, Lydia A Suh4, Roderick G Carter4, Ava R Weibman4, Kathryn E Hulse4, Kathleen E Harris4, Anju T Peters4, Leslie C Grammer4, Bruce K Tan5, Kevin Welch5, Stephanie Shintani-Smith5, David B Conley5, Robert C Kern5, Shigeharu Fujieda3, Robert P Schleimer4. 1. Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. Electronic address: yimoto@u-fukui.ac.jp. 2. Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill. 3. Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. 4. Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill. 5. Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Abstract
BACKGROUND: Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory disease subdivided based on the presence or absence of nasal polyps (NPs). Histologic features of chronic rhinosinusitis with nasal polyps (CRSwNP) include inflammatory cell infiltration and excessive fibrin deposition in NPs. Thrombin-activatable fibrinolysis inhibitor (TAFI) is an enzyme that plays an antifibrinolytic role in the body. The significance of TAFI has been documented in patients with chronic inflammatory diseases, including chronic lung disease; however, it has not been evaluated in the pathogenesis of NPs. OBJECTIVE: The objective of this study was to evaluate the potential role of TAFI in the pathogenesis of NPs. METHODS: Nasal lavage fluid was collected from control subjects and patients with CRS. We measured levels of thrombin/anti-thrombin complex (TATc) and TAFI protein using an ELISA. RESULTS: TATc levels in nasal lavage fluid were significantly increased in patients with CRSwNP and patients with chronic rhinosinusitis without nasal polyps (CRSsNP) compared with control subjects, and TAFI levels in nasal lavage fluid were also significantly increased in patients with CRSwNP compared with those in control subjects and patients with CRSsNP. There was a significant correlation between TATc and TAFI levels in nasal lavage fluid. Interestingly, patients with CRS and asthma showed increased TATc and TAFI levels in nasal lavage fluid compared with those in patients with CRS without asthma, especially patients with CRSwNP. CONCLUSIONS: Increased TATc and TAFI levels in nasal passages of patients with CRSwNP might participate in fibrin deposition in NPs and might play a role in the pathogenesis of CRSwNP and asthma.
BACKGROUND:Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory disease subdivided based on the presence or absence of nasal polyps (NPs). Histologic features of chronic rhinosinusitis with nasal polyps (CRSwNP) include inflammatory cell infiltration and excessive fibrin deposition in NPs. Thrombin-activatable fibrinolysis inhibitor (TAFI) is an enzyme that plays an antifibrinolytic role in the body. The significance of TAFI has been documented in patients with chronic inflammatory diseases, including chronic lung disease; however, it has not been evaluated in the pathogenesis of NPs. OBJECTIVE: The objective of this study was to evaluate the potential role of TAFI in the pathogenesis of NPs. METHODS: Nasal lavage fluid was collected from control subjects and patients with CRS. We measured levels of thrombin/anti-thrombin complex (TATc) and TAFI protein using an ELISA. RESULTS: TATc levels in nasal lavage fluid were significantly increased in patients with CRSwNP and patients with chronic rhinosinusitis without nasal polyps (CRSsNP) compared with control subjects, and TAFI levels in nasal lavage fluid were also significantly increased in patients with CRSwNP compared with those in control subjects and patients with CRSsNP. There was a significant correlation between TATc and TAFI levels in nasal lavage fluid. Interestingly, patients with CRS and asthma showed increased TATc and TAFI levels in nasal lavage fluid compared with those in patients with CRS without asthma, especially patients with CRSwNP. CONCLUSIONS: Increased TATc and TAFI levels in nasal passages of patients with CRSwNP might participate in fibrin deposition in NPs and might play a role in the pathogenesis of CRSwNP and asthma.
Authors: J Daan de Boer; Christof J Majoor; Cornelis van 't Veer; Elisabeth H D Bel; Tom van der Poll Journal: Blood Date: 2012-01-18 Impact factor: 22.113
Authors: Mahboobeh Mahdavinia; Roderick G Carter; Christopher J Ocampo; Whitney Stevens; Atsushi Kato; Bruce K Tan; Robert C Kern; David B Conley; Rakesh Chandra; Kathryn E Hulse; Lydia A Suh; James E Norton; Anju T Peters; Leslie C Grammer; Lawrence B Schwartz; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2014-03-15 Impact factor: 10.793
Authors: Marlous M S Sneeboer; Christof J Majoor; Anne de Kievit; Joost C M Meijers; Tom van der Poll; Pieter W Kamphuisen; Elisabeth H Bel Journal: J Allergy Clin Immunol Date: 2015-12-20 Impact factor: 10.793
Authors: Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich Journal: Otolaryngol Head Neck Surg Date: 2004-12 Impact factor: 3.497
Authors: Whitney W Stevens; Anju T Peters; Lydia Suh; James E Norton; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Margrit Urbanek; Robert P Schleimer; Kathryn E Hulse Journal: Immun Inflamm Dis Date: 2015-02-12
Authors: Aiko I Klingler; Whitney W Stevens; Bruce K Tan; Anju T Peters; Julie A Poposki; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2020-12-14 Impact factor: 10.793
Authors: Ping-Ping Cao; Bao-Feng Wang; James E Norton; Lydia A Suh; Roderick G Carter; Whitney W Stevens; Anna G Staudacher; Julia H Huang; Kathryn E Hulse; Anju T Peters; Leslie C Grammer; David B Conley; Kevin C Welch; Robert C Kern; Zheng Liu; Jingying Ye; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2022-03-07 Impact factor: 14.290
Authors: Cai-Ling Chen; Yin Yao; Li Pan; Si-Tao Hu; Jin Ma; Zhi-Chao Wang; Robert C Kern; Robert P Schleimer; Zheng Liu Journal: J Allergy Clin Immunol Date: 2020-02-26 Impact factor: 14.290
Authors: Jacob G Eide; Jeffanie Wu; Whitney W Stevens; Junqin Bai; Songwang Hou; Julia H Huang; Jacob Rosenberg; Paul Utz; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Robert C Kern; Kathryn E Hulse; Anju T Peters; Leslie C Grammer; Ming Zhao; Paul Lindholm; Robert P Schleimer; Bruce K Tan Journal: Clin Exp Allergy Date: 2022-03-14 Impact factor: 5.401